Cargando…

CD4(+)T cell specific B7-H1 selectively inhibits proliferation of naïve T cells and Th17 differentiation in experimental autoimmune encephalomyelitis

It is widely acknowledged that interleukin 17-producing T helper (Th17) cells are critically participant in the pathogenesis of multiple sclerosis. In the current study, we identified that the expression of CD4(+)T cells specific co-inhibitory molecule B7-homologue 1(B7-H1) in spleenocytes and monon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Sheng-Jia, Ding, Mei-Ling, Wang, Li-Juan, Wu, Jie-Heng, Han, Dong-Hui, Zheng, Guo-Xu, Guo, Zhang-Yan, Xi, Wen-Jin, Qin, Wei-Jun, Yang, An-Gang, Wen, Wei-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685729/ https://www.ncbi.nlm.nih.gov/pubmed/29163808 http://dx.doi.org/10.18632/oncotarget.21357

Ejemplares similares

BAFF Promotes Th17 Cells and Aggravates Experimental Autoimmune Encephalomyelitis
por: Zhou, Xiaohui, et al.
Publicado: (2011)

Rifampicin attenuates experimental autoimmune encephalomyelitis by inhibiting pathogenic Th17 cells responses
por: Ma, Ke, et al.
Publicado: (2016)

SKI Expression Suppresses Pathogenic Th17 Cell Response and Mitigates Experimental Autoimmune Encephalomyelitis
por: Li, Ping, et al.
Publicado: (2021)

Functional and Pathogenic Differences of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis
por: Domingues, Helena S., et al.
Publicado: (2010)

CD73 is expressed by inflammatory Th17 cells in experimental autoimmune encephalomyelitis but does not limit differentiation or pathogenesis
por: Hernandez-Mir, Gerard, et al.
Publicado: (2017)

Carnosol Modulates Th17 Cell Differentiation and Microglial Switch in Experimental Autoimmune Encephalomyelitis
por: Li, Xing, et al.
Publicado: (2018)

CCR6 and CXCR6 Identify the Th17 Cells With Cytotoxicity in Experimental Autoimmune Encephalomyelitis
por: Hou, Lifei, et al.
Publicado: (2022)

Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells
por: Qiu, Xuemei, et al.
Publicado: (2018)

Eomesodermin in CD4(+)T cells is essential for Ginkgolide K ameliorating disease progression in experimental autoimmune encephalomyelitis
por: Chen, Sheng, et al.
Publicado: (2021)

Silybin Alleviates Experimental Autoimmune Encephalomyelitis by Suppressing Dendritic Cell Activation and Th17 Cell Differentiation
por: Yang, Huan-Li, et al.
Publicado: (2021)

Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance
por: Zhou, Yan, et al.
Publicado: (2016)

Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation
por: Zhang, Han, et al.
Publicado: (2017)

Kirenol Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Differentiation of Th1 and Th17 Cells and Inducing Apoptosis of Effector T Cells
por: Xiao, Juan, et al.
Publicado: (2015)

Alpinia oxyphylla Fruit Extract Ameliorates Experimental Autoimmune Encephalomyelitis through the Regulation of Th1/Th17 Cells
por: Huang, Kuo-Kuei, et al.
Publicado: (2019)

4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis
por: Weng, Wen-Tsan, et al.
Publicado: (2021)

Therapeutic Effect of Ginsenoside Rd on Experimental Autoimmune Encephalomyelitis Model Mice: Regulation of Inflammation and Treg/Th17 Cell Balance
por: Jin, Bo, et al.
Publicado: (2020)

Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis
por: Cummings, Matthew, et al.
Publicado: (2018)

Nasal delivery of Fasudil‐modified immune cells exhibits therapeutic potential in experimental autoimmune encephalomyelitis
por: Guo, Shang‐De, et al.
Publicado: (2019)

Anemoside A(3) ameliorates experimental autoimmune encephalomyelitis by modulating T helper 17 cell response
por: Ip, Fanny C. F., et al.
Publicado: (2017)

Prostaglandin I(2) Signaling Drives Th17 Differentiation and Exacerbates Experimental Autoimmune Encephalomyelitis
por: Zhou, Weisong, et al.
Publicado: (2012)

Auto-Reactive Th17-Cells Trigger Obsessive-Compulsive-Disorder Like Behavior in Mice With Experimental Autoimmune Encephalomyelitis
por: Kant, Ravi, et al.
Publicado: (2018)

Parthenolide Suppresses T Helper 17 and Alleviates Experimental Autoimmune Encephalomyelitis
por: Zhang, Zhihui, et al.
Publicado: (2022)

SOX-5 activates a novel RORγt enhancer to facilitate experimental autoimmune encephalomyelitis by promoting Th17 cell differentiation
por: Tian, Yi, et al.
Publicado: (2021)

A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation
por: Guo, Wei, et al.
Publicado: (2015)

MiR-384 Regulates the Th17/Treg Ratio during Experimental Autoimmune Encephalomyelitis Pathogenesis
por: Qu, Xuebin, et al.
Publicado: (2017)

The antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation
por: Smith, Katie J., et al.
Publicado: (2022)

Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation
por: Acharya, Suman, et al.
Publicado: (2018)

Rotating magnetic field ameliorates experimental autoimmune encephalomyelitis by promoting T cell peripheral accumulation and regulating the balance of Treg and Th1/Th17
por: Zhan, Tianying, et al.
Publicado: (2020)

The CTRP3-AdipoR2 Axis Regulates the Development of Experimental Autoimmune Encephalomyelitis by Suppressing Th17 Cell Differentiation
por: Murayama, Masanori A., et al.
Publicado: (2021)

STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis
por: Zhao, Junjie, et al.
Publicado: (2021)

Impaired Autoimmune T Helper 17 Cell Responses Following DNA Vaccination against Rat Experimental Autoimmune Encephalomyelitis
por: Andersson, Åsa, et al.
Publicado: (2008)

CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells
por: Chung, Chen-Yen, et al.
Publicado: (2016)

Opposing T Cell Responses in Experimental Autoimmune Encephalomyelitis
por: Saligrama, Naresha, et al.
Publicado: (2019)

Humoral response in experimental autoimmune encephalomyelitis targets neural precursor cells in the central nervous system of naive rodents
por: Kesidou, Evangelia, et al.
Publicado: (2017)

Alpha-tocopherol ameliorates experimental autoimmune encephalomyelitis through the regulation of Th1 cells
por: Xue, Haikuo, et al.
Publicado: (2016)

GM-CSF-Producing Th Cells in Rats Sensitive and Resistant to Experimental Autoimmune Encephalomyelitis
por: Stojić-Vukanić, Zorica, et al.
Publicado: (2016)

Prevention and Treatment of Experimental Autoimmune Encephalomyelitis by Soluble CD83
por: Zinser, Elisabeth, et al.
Publicado: (2004)

Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis
por: Aarts, Suzanne ABM, et al.
Publicado: (2019)

C-Reactive Protein Suppresses the Th17 Response Indirectly by Attenuating the Antigen Presentation Ability of Monocyte Derived Dendritic Cells in Experimental Autoimmune Encephalomyelitis
por: Shen, Zhi-Yuan, et al.
Publicado: (2021)

Nobiletin suppresses the development of experimental autoimmune encephalomyelitis mediated by modulation of T helper 17 cell differentiation
por: Nakamoto, Akiko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fgcdkrtdsmfd48miq5sat0fls1